© Reuters. DSM: surrounded for an increase of annual objectives
DSM gained 5.4 percent in Amsterdam, surrounded by to raise its forecast of annual results, supported by price is substantially higher for certain vitamins due to disruptions of supply in the sector.
Thus, the chemist Dutch is now forecasting a growth of approximately 25% of its adjusted EBITDA in 2018. In the first quarter, he has seen it grow from 55% to € 535 million, or 29% above the consensus.
Copyright (c) 2018 CercleFinance.com. All rights reserved.
